Get the Stockscreener App
0.4101
7.01%
-0.0309
After Hours:
.43
0.0199
+4.85%
Applied Therapeutics Inc Stock (APLT) Forecast
The Applied Therapeutics Inc (APLT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $35.22, representing a +8,488% increase from the current price of $0.4101. The highest analyst price target is $42.97, and the lowest is $27.47.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month APLT Price Target
Average 27.98
(+6,724% Upside)
Is Applied Therapeutics Inc (APLT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 32.86 | Neutral |
| STOCH(9,6) | 17.56 | Buy |
| STOCHRSI(14) | 19.98 | Buy |
| MACD(12,26) | -0.0397 | Sell |
| ADX(14) | 21.51 | Neutral |
| William %R | -93.37 | Buy |
| CCI(14) | -212.74 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.5065
Sell
|
0.4832
Sell
|
| MA20 |
0.5151
Sell
|
0.5074
Sell
|
| MA50 |
0.5434
Sell
|
0.8309
Sell
|
| MA100 |
2.0327
Sell
|
1.8971
Sell
|
| MA200 |
4.2806
Sell
|
3.0836
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, APLT could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on APLT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 32.86 indicates that APLT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 17.56 indicates that APLT is oversold. This indicates that APLT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 19.98 indicates that APLT is oversold. This suggests that APLT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.51 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -212.74 indicates that APLT is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term APLT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Applied Therapeutics Inc financial reports and earnings history, Applied Therapeutics Inc (APLT) stock could reach $2.1667 by 2030, $7.5949 by 2040 and $16.70 by 2050. See the projected annual prices until 2050 of the Applied Therapeutics Inc stock below:
- Applied Therapeutics Inc (APLT) is expected to reach an average price of $3.0766 in 2035, with a high prediction of $3.4291 and a low estimate of $3.4026. This indicates an $650.22% rise from the last recorded price of $0.4101.
- Applied Therapeutics Inc (APLT) stock is projected to chart a bullish course in 2040, with an average price target of $7.8049, representing an $1,803% surge from its current level. The forecast ranges from a conservative $7.9085 to a sky-high $7.5949.
- Our analysts predict Applied Therapeutics Inc (APLT) to jump 3,064% by 2045, soaring from $13.05 to an average price of $12.98, potentially reaching $13.18. While $13.05 is the low estimate, the potential upside is significant.
- Applied Therapeutics Inc (APLT) stock is expected to climb by 2050, reaching an average of $16.83, a $4,003% jump from its current level. However, a wide range of estimates exists, with high and low targets of $16.70 and $16.64, respectively, highlighting the market's uncertainty.
Applied Therapeutics Inc Stock (APLT) Year by Year Forecast
Applied Therapeutics Inc Stock (APLT) Price Forecast for 2025
Applied Therapeutics Inc Stock (APLT) is expected to reach an average price of $31.59 in 2025, with a high prediction of $52.26 and a low estimate of $10.93. This indicates an +7,604% rise from the last recorded price of $0.4101.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $30.75 | $27.47 | $42.97 | +7,399% |
| June, 2025 | $42.58 | $29.62 | $46.68 | +10,282% |
| July, 2025 | $30.44 | $29.48 | $47.05 | +7,322% |
| August, 2025 | $23.50 | $21.72 | $32.32 | +5,631% |
| September, 2025 | $24.41 | $19.03 | $28.52 | +5,852% |
| October, 2025 | $19.50 | $17.53 | $23.97 | +4,654% |
| November, 2025 | $15.30 | $14.07 | $22.44 | +3,631% |
| December, 2025 | $11.83 | $10.93 | $19.79 | +2,785% |
Applied Therapeutics Inc Stock (APLT) Price Forecast for 2026
The predicted value for Applied Therapeutics Inc (APLT) in 2026 is set at an average of $17.10. Estimates vary from a peak of $25.29 to a trough of $8.9024, indicating an +4,069% surge from the present price of $0.4101.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $18.66 | $8.9227 | $19.90 | +4,451% |
| February, 2026 | $17.72 | $14.68 | $21.90 | +4,220% |
| March, 2026 | $15.19 | $14.78 | $19.59 | +3,604% |
| April, 2026 | $17.23 | $14.98 | $25.29 | +4,102% |
| May, 2026 | $15.40 | $11.77 | $18.32 | +3,656% |
| June, 2026 | $11.99 | $11.69 | $15.72 | +2,823% |
| July, 2026 | $12.76 | $9.3502 | $15.22 | +3,011% |
| August, 2026 | $18.13 | $12.37 | $20.11 | +4,322% |
| September, 2026 | $15.35 | $14.83 | $21.29 | +3,642% |
| October, 2026 | $11.85 | $10.96 | $16.70 | +2,789% |
| November, 2026 | $11.75 | $9.4793 | $14.81 | +2,765% |
| December, 2026 | $13.54 | $8.9024 | $13.66 | +3,203% |
Applied Therapeutics Inc Stock (APLT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Applied Therapeutics Inc (APLT) is $7.5687, with a high forecast of $15.04 and a low forecast of $0.0926. This indicates an +1,746% increase from the last price of $0.4101.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $10.66 | $9.3254 | $15.04 | +2,498% |
| February, 2027 | $6.8484 | $6.1884 | $12.34 | +1,570% |
| March, 2027 | $5.8614 | $4.7708 | $7.8596 | +1,329% |
| April, 2027 | $0.7661 | $0.0926 | $5.942 | +86.82% |
| May, 2027 | $1.5637 | $1.2655 | $1.0937 | +281.30% |
| June, 2027 | $2.2507 | $1.7831 | $1.9707 | +448.82% |
| July, 2027 | $1.5183 | $1.6483 | $1.7701 | +270.22% |
| August, 2027 | $1.7858 | $1.4877 | $1.6958 | +335.47% |
| September, 2027 | $2.2628 | $1.9952 | $2.1334 | +451.77% |
| October, 2027 | $2.8151 | $2.5121 | $2.4604 | +586.44% |
| November, 2027 | $2.588 | $2.7171 | $2.6993 | +531.06% |
| December, 2027 | $2.0849 | $2.2949 | $2.5429 | +408.40% |
Applied Therapeutics Inc Stock (APLT) Price Forecast for 2028
In 2028, Applied Therapeutics Inc (APLT) is projected to reach an average price of $2.2205, with a high projection of $2.7715 and a low estimate of $1.6695. This indicates an +441.45% rise from the last price of $0.4101.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.0625 | $2.2137 | $2.1131 | +402.93% |
| February, 2028 | $2.86 | $2.1819 | $2.4709 | +597.39% |
| March, 2028 | $2.7002 | $2.7078 | $2.7715 | +558.42% |
| April, 2028 | $2.2647 | $2.5347 | $2.5265 | +452.22% |
| May, 2028 | $2.5716 | $2.499 | $2.5016 | +527.07% |
| June, 2028 | $2.0792 | $2.2592 | $2.371 | +407.00% |
| July, 2028 | $2.2268 | $2.1979 | $2.1174 | +442.98% |
| August, 2028 | $2.2416 | $2.2645 | $2.2338 | +446.59% |
| September, 2028 | $2.3153 | $2.3905 | $2.3125 | +464.58% |
| October, 2028 | $1.5189 | $1.6695 | $2.1508 | +270.37% |
| November, 2028 | $1.5959 | $1.7183 | $1.7056 | +289.14% |
| December, 2028 | $1.6535 | $1.6747 | $1.6235 | +303.18% |
Applied Therapeutics Inc Stock (APLT) Price Forecast for 2029
The 2029 price forecast for Applied Therapeutics Inc Stock (APLT) is $3.3959 on average, with a high prediction of $6.7902 and a low estimate of $0.00166. This represents an +728.07% increase from the previous price of $0.4101.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.1804 | $1.3161 | $1.5649 | +187.84% |
| February, 2029 | $1.588 | $1.537 | $1.478 | +287.22% |
| March, 2029 | $0.1756 | $1.0356 | $1.5673 | -57.18% |
| April, 2029 | $0.3332 | $0.5032 | $0.3038 | -18.76% |
| May, 2029 | $0.7901 | $0.3834 | $0.5401 | +92.67% |
| June, 2029 | $0.3723 | $0.5177 | $0.6595 | -9.22% |
| July, 2029 | $0.4453 | $0.0471 | $1.7247 | +8.58% |
| August, 2029 | $0.3777 | $0.1534 | $0.5671 | -7.89% |
| September, 2029 | $4.5202 | $0.00166 | $6.7902 | +1,002% |
| October, 2029 | $4.2532 | $2.792 | $5.1278 | +937.11% |
| November, 2029 | $1.7756 | $1.6606 | $4.1638 | +332.97% |
| December, 2029 | $1.1288 | $1.4488 | $2.1968 | +175.25% |
Applied Therapeutics Inc Stock (APLT) Price Forecast for 2030
Applied Therapeutics Inc Stock (APLT) is expected to reach an average price of $23.86 in 2030, with a high forecast of $47.12 and a low forecast of $0.5909. This signifies an +5,717% surge from the last price of $0.4101.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.7927 | $1.3676 | $2.1667 | +580.99% |
| February, 2030 | $2.1979 | $2.3879 | $2.1625 | +435.94% |
| March, 2030 | $1.123 | $2.3104 | $1.5855 | +173.85% |
| April, 2030 | $1.4332 | $1.3206 | $0.8318 | +249.48% |
| May, 2030 | $0.0279 | $0.7521 | $0.7942 | -93.21% |
| June, 2030 | $6.3827 | $0.5909 | $9.8303 | +1,456% |
| July, 2030 | $10.79 | $3.4951 | $15.72 | +2,531% |
| August, 2030 | $16.85 | $8.04 | $18.33 | +4,010% |
| September, 2030 | $38.07 | $13.65 | $42.85 | +9,183% |
| October, 2030 | $29.81 | $27.81 | $47.12 | +7,169% |
| November, 2030 | $20.37 | $8.3181 | $34.60 | +4,867% |
| December, 2030 | $32.96 | $18.50 | $37.94 | +7,938% |
1.23%
1.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):